A Globally Rising Burden of Sexually Transmitted Diseases (STDs)
Pharma News for CG Oncology, Amgen, Elevar, and GSK
CG Oncology Teams Up With Merck &...

FDA Gives Green Signal to First Measles Vaccine in Almost 50 Years GSK announced that the company's vaccine...

pharma-news-for-noxxon-nuvalent-stryker-exact-sciences
Noxxon’s NOX-A12 clinical trial; Exac...

Noxxon continues enrolment in a glioblastoma therapy trial Noxxon Pharma continues subject enrolment in the...

femtech-market
FemTech Market: With 100+ Startups in...

Gender disparity is not new to ears. To look at all the corners, women have been and are still affected&hel...

global-burden-of-sexually-transmitted-diseases-std
A Globally Rising Burden of Sexually Transmitted Diseases (STDs)

Caused by bacteria, viruses, and parasites, Sexually transmitted diseases (STDs) are a global health burden and it seems they are likely to maintain their status of being so in coming years also, ...


latest pharma news
AZ, Daiichi inks an oncology deal; Moderna begins Phase III trial of its COVID-19 vaccine; No goo...

AZ, Daiichi put their trust into TROP2-based drugs, inks an oncology deal to together develop and commercialize DS-1062 AstraZeneca has inked an oncology deal with Daiichi Sankyo to jointly de...


recent-pharma-news-and-update
Olema raises $54M; T3 Pharma bags $27M to advance bacterial cancer therapy program; Biofourmis an...

Olema Oncology raises USD 54 Million for breast cancer program Olema Oncology has raised USD 54 million to push its lead program into the clinic and boost its R&D efforts in other areas.&nb...


latest-pharma-news-and-updates
Orchard licenses gene therapy tech from GSK; Glympse raises $46M; FDA voted to recommend Terlipre...

Orchard licenses the gene therapy technology from GlaxoSmithKline  Orchard Therapeutics has permitted lentiviral stable cell line technology from GlaxoSmithKline for its use in hematopoiet...


Postpartum Depression Market | PPD Market
Spot the Signs and Fight Postpartum Depressions

The Postpartum Depression Market Size in the 7MM was estimated to be USD 138.75 Million in 2017 and is expected to grow further with rise in PPD prevalence and immense opportunities with only a si...


pharma-news
Lassen’s anti-IL-11 antibody; PTC’s COVID-19 trial; Lenzilumab’s result; Orca raises $192M

Lassen Therapeutics to create anti-IL-11 antibody for cancer and fibrosis Lassen Therapeutics is revealing USD 31 million from Frazier Healthcare Partners, Alta Venture and Longwood Fund and ha...


PD1-PDL1 inhibitors
PD1-PDL1 inhibitors...

Cancer immunotherapy which is known to reactivate weakened immune cells of cancer patients, has yiel.....

Relapsing/Remitting Multiple Sclerosis
Relapsing/Remitting Multi...

Relapsing-Remitting Multiple Sclerosis (RRMS) is the most common form of Multiple Sclerosis. The ind.....

Metachromatic Leukodystrophy Newsletter
Metachromatic Leukodystro...

Metachromatic Leukodystrophy (MLD) is a rare hereditary disease characterized by the accumulation of.....

Editor's Pick
Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...

The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...

Emerging Market for Organ on a Chip

The organ on a chip is a microfluidic culture device that recapitulates the complicated...

Global Top Players in Intraocular Lens (IOL) Market

 An Intraocular Lens implant is a synthetic, artificial lens placed inside the eye...

Investigating the Pipeline for Ankylosing Spondylitis Treatment Landscape

Ankylosing Spondylitis is a form of arthritis that primarily affects the spine. It caus...

LAG 3: A Promising Next Generation Cancer Immunotherapy

Immunotherapy also called biologic therapy, is a type of cancer treatment that boosts t...